A detailed history of Stifel Financial Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Stifel Financial Corp holds 2,142,304 shares of ABT stock, worth $245 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
2,142,304
Previous 2,060,877 3.95%
Holding current value
$245 Million
Previous $214 Million 14.06%
% of portfolio
0.26%
Previous 0.25%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$100.07 - $118.13 $8.15 Million - $9.62 Million
81,427 Added 3.95%
2,142,304 $244 Million
Q2 2024

Aug 13, 2024

BUY
$100.73 - $112.44 $13.7 Million - $15.3 Million
136,144 Added 7.07%
2,060,877 $214 Million
Q1 2024

May 13, 2024

BUY
$109.52 - $120.96 $10.7 Million - $11.8 Million
97,811 Added 5.35%
1,924,733 $219 Million
Q4 2023

Feb 12, 2024

BUY
$90.19 - $110.4 $463,396 - $567,235
5,138 Added 0.28%
1,826,922 $201 Million
Q3 2023

Nov 13, 2023

BUY
$95.53 - $114.62 $3.98 Million - $4.78 Million
41,688 Added 2.34%
1,821,784 $176 Million
Q2 2023

Aug 14, 2023

BUY
$100.78 - $112.29 $7.35 Million - $8.19 Million
72,957 Added 4.27%
1,780,096 $194 Million
Q1 2023

May 12, 2023

SELL
$96.86 - $114.01 $4.13 Million - $4.86 Million
-42,662 Reduced 2.44%
1,707,139 $173 Million
Q4 2022

Feb 13, 2023

SELL
$95.06 - $111.52 $3.71 Million - $4.35 Million
-38,993 Reduced 2.18%
1,749,801 $192 Million
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $1.42 Million - $1.65 Million
-14,712 Reduced 0.82%
1,788,794 $173 Million
Q2 2022

Aug 15, 2022

SELL
$102.07 - $123.37 $1.04 Million - $1.25 Million
-10,164 Reduced 0.56%
1,803,506 $196 Million
Q1 2022

May 13, 2022

BUY
$114.02 - $139.04 $6.62 Million - $8.07 Million
58,018 Added 3.3%
1,813,670 $215 Million
Q4 2021

Feb 14, 2022

BUY
$115.53 - $141.46 $8.19 Million - $10 Million
70,900 Added 4.21%
1,755,652 $247 Million
Q3 2021

Nov 15, 2021

BUY
$116.66 - $129.06 $4.13 Million - $4.57 Million
35,407 Added 2.15%
1,684,752 $199 Million
Q2 2021

Aug 13, 2021

BUY
$105.79 - $124.53 $1.72 Million - $2.03 Million
16,264 Added 1.0%
1,649,345 $191 Million
Q1 2021

May 14, 2021

BUY
$108.84 - $128.23 $7.09 Million - $8.35 Million
65,111 Added 4.15%
1,633,081 $196 Million
Q4 2020

Feb 12, 2021

BUY
$105.0 - $114.42 $1 Million - $1.09 Million
9,534 Added 0.61%
1,567,970 $172 Million
Q3 2020

Nov 16, 2020

BUY
$91.64 - $111.29 $8.22 Million - $9.99 Million
89,752 Added 6.11%
1,558,436 $170 Million
Q2 2020

Aug 14, 2020

BUY
$76.57 - $98.0 $5.88 Million - $7.53 Million
76,786 Added 5.52%
1,468,684 $134 Million
Q1 2020

May 14, 2020

BUY
$62.82 - $91.86 $3.27 Million - $4.78 Million
52,068 Added 3.89%
1,391,898 $110 Million
Q4 2019

Feb 13, 2020

BUY
$78.51 - $87.4 $1.96 Million - $2.18 Million
24,995 Added 1.9%
1,339,830 $116 Million
Q3 2019

Nov 19, 2019

BUY
$81.84 - $88.74 $42,638 - $46,233
521 Added 0.04%
1,314,835 $110 Million
Q3 2019

Nov 13, 2019

SELL
$81.84 - $88.74 $3.52 Million - $3.82 Million
-43,049 Reduced 3.17%
1,314,314 $110 Million
Q2 2019

Aug 14, 2019

BUY
$72.88 - $85.0 $2.49 Million - $2.91 Million
34,203 Added 2.58%
1,357,363 $114 Million
Q1 2019

May 14, 2019

SELL
$66.22 - $80.06 $5.26 Million - $6.37 Million
-79,503 Reduced 5.67%
1,323,160 $106 Million
Q4 2018

Feb 13, 2019

SELL
$65.56 - $74.27 $1.4 Million - $1.59 Million
-21,365 Reduced 1.5%
1,402,663 $101 Million
Q3 2018

Nov 13, 2018

BUY
$60.81 - $73.36 $3.51 Million - $4.24 Million
57,764 Added 4.23%
1,424,028 $104 Million
Q2 2018

Aug 14, 2018

SELL
$57.57 - $63.54 $2.81 Million - $3.1 Million
-48,853 Reduced 3.45%
1,366,264 $83.2 Million
Q1 2018

May 11, 2018

SELL
$56.27 - $63.62 $13.1 Million - $14.8 Million
-232,440 Reduced 14.11%
1,415,117 $84.8 Million
Q4 2017

Feb 14, 2018

SELL
$53.68 - $57.47 $4.08 Million - $4.37 Million
-76,033 Reduced 4.41%
1,647,557 $94.1 Million
Q3 2017

Nov 13, 2017

BUY
$48.06 - $53.64 $82.8 Million - $92.5 Million
1,723,590
1,723,590 $0

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.